NCT02367885View on ClinicalTrials.gov

Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric Participants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Influenza Infection
Interventions
DRUG

TAK-850 0.5 mL injection

TAK-850 injection

DRUG

TAK-850 0.25 mL injection

TAK-850 intramuscular injection

Trial Locations (2)

Unknown

Chuou-ku

Setagaya-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY